CN105461603A - 一种福多司坦的制备方法 - Google Patents
一种福多司坦的制备方法 Download PDFInfo
- Publication number
- CN105461603A CN105461603A CN201511002173.8A CN201511002173A CN105461603A CN 105461603 A CN105461603 A CN 105461603A CN 201511002173 A CN201511002173 A CN 201511002173A CN 105461603 A CN105461603 A CN 105461603A
- Authority
- CN
- China
- Prior art keywords
- fudosteine
- preparation
- room temperature
- cys
- cooled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KINWYTAUPKOPCQ-YFKPBYRVSA-N Fudosteine Chemical compound OC(=O)[C@@H](N)CSCCCO KINWYTAUPKOPCQ-YFKPBYRVSA-N 0.000 title claims abstract description 23
- 229950006783 fudosteine Drugs 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 54
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims description 46
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- 238000010792 warming Methods 0.000 claims description 23
- 235000019441 ethanol Nutrition 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000003513 alkali Substances 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 235000010755 mineral Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 2
- 235000013878 L-cysteine Nutrition 0.000 abstract 1
- 239000004201 L-cysteine Substances 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000012043 crude product Substances 0.000 description 21
- 238000007605 air drying Methods 0.000 description 14
- 239000012065 filter cake Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001944 cysteine derivatives Chemical class 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511002173.8A CN105461603B (zh) | 2015-12-29 | 2015-12-29 | 一种福多司坦的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511002173.8A CN105461603B (zh) | 2015-12-29 | 2015-12-29 | 一种福多司坦的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105461603A true CN105461603A (zh) | 2016-04-06 |
CN105461603B CN105461603B (zh) | 2018-04-17 |
Family
ID=55599821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511002173.8A Active CN105461603B (zh) | 2015-12-29 | 2015-12-29 | 一种福多司坦的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461603B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112778177A (zh) * | 2019-11-08 | 2021-05-11 | 江苏正大丰海制药有限公司 | 一种高质量的福多司坦杂质标准品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126352A (ja) * | 2003-10-23 | 2005-05-19 | Mitsubishi Pharma Corp | 下痢治療薬 |
CN101717356A (zh) * | 2009-12-16 | 2010-06-02 | 天津工业大学 | 一种微波合成祛痰药物福多司坦的方法 |
CN101851185A (zh) * | 2009-10-20 | 2010-10-06 | 西华大学 | 一种福多司坦的制备与纯化方法 |
-
2015
- 2015-12-29 CN CN201511002173.8A patent/CN105461603B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126352A (ja) * | 2003-10-23 | 2005-05-19 | Mitsubishi Pharma Corp | 下痢治療薬 |
CN101851185A (zh) * | 2009-10-20 | 2010-10-06 | 西华大学 | 一种福多司坦的制备与纯化方法 |
CN101717356A (zh) * | 2009-12-16 | 2010-06-02 | 天津工业大学 | 一种微波合成祛痰药物福多司坦的方法 |
Non-Patent Citations (2)
Title |
---|
余红等: "福多司坦片的制备工艺研究", 《药学与临床研究》 * |
徐桂清等: "福多司坦合成工艺研究", 《河南师范大学学报(自然科学版)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112778177A (zh) * | 2019-11-08 | 2021-05-11 | 江苏正大丰海制药有限公司 | 一种高质量的福多司坦杂质标准品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105461603B (zh) | 2018-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105330609B (zh) | 一种制备lcz696的方法 | |
CN108774278A (zh) | 一种制备尼克酰胺核苷盐的方法 | |
CN102558097B (zh) | 一种改进的雷诺嗪合成方法 | |
CN102060753B (zh) | 一种4-苯胺基哌啶类镇痛药的精制方法 | |
CN104910231A (zh) | 25-羟基-7-脱氢胆固醇合成方法 | |
CN104072565B (zh) | 一种高收率的17α‑羟基黄体酮的简捷制备方法 | |
CN105461603A (zh) | 一种福多司坦的制备方法 | |
CN102079721B (zh) | 一种托拉塞米化合物及其制法 | |
EP2669293A1 (en) | Preparation method of rocuronium | |
CN104263795A (zh) | 制备手性α-环烷基甘氨酸的方法 | |
CN104557899B (zh) | 一种阿齐沙坦i晶型晶体的制备方法 | |
CN103739545B (zh) | 一种简便的维生素b6的制备方法 | |
CN103102324A (zh) | 一种利可君的制备方法 | |
CN103951669B (zh) | 一种阿拉格列汀关键中间体的合成方法 | |
CN108658871A (zh) | 周效磺胺中间体4,6-二氯-5-甲氧基嘧啶的制备方法 | |
CN104710346A (zh) | 一种合成顺式-1-苄基-3-甲氨基-4-甲基-哌啶的方法 | |
CN104326954A (zh) | 一种福多司坦的合成方法 | |
CN114163411A (zh) | 一种对映体纯二氢杨梅素制备方法 | |
CN103896859A (zh) | 合成胞嘧啶的工艺 | |
CN105503853A (zh) | 头孢地尼活性硫酯的合成方法 | |
CN111377840A (zh) | 一种r-(+)-二氢硫辛酸的制备方法 | |
CN103304527A (zh) | 一种新的5-硝基苯并呋喃-2-甲酸的制备方法 | |
CN105968108B (zh) | 一种合成帕布昔利布中间体的方法 | |
CN103102316A (zh) | ZD1839Form 1晶型的制备方法 | |
CN102070474A (zh) | 甜菜碱的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160623 Address after: 264205 Shandong city of Weihai province by the district Gushan Town No. 18 South Road, No. 19 North Road, No. 3 East Road, the west five Applicant after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Shandong city of Weihai province by the district Gushan Town No. 18 South Road, No. 19 North Road, No. 3 East Road, the west five Applicant before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant before: WEIHAI DIJIA PHARMACEUTICAL Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191031 Address after: 264205 Guangzhou East Road South and an East Road East, Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Co-patentee after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Co-patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Shandong city of Weihai province by the district Gushan Town No. 18 South Road, No. 19 North Road, No. 3 East Road, the west five Co-patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210720 Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Effective date of registration: 20210720 Address after: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 268, Tianrun Road, Wendeng Economic and Technological Development Zone, Weihai City, Shandong Province, 264200 Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP03 | Change of name, title or address |